Aim of this study was to evaluate the effect of manidipine-simvastatin combination on plasma tissue plasminogen activator (t-PA) and inhibitor (PAI-1) activity, on plasma intercellurar adhesion molecule type-1 (ICAM-1) and on serum C-reactive protein (CRP) in hypertensive, hypercholesterolemic patients.
P-455 STUDY ON HYPERCOAGULATION AND HYPOFIBRINOLYSIS STATE IN PATIENTS WITH ATRIAL FIBRILLATION AND ESSENTIAL HYPERTENSION
Objective: To study the change of coagulation and fibrinolysis system and its clinical significance in patients with atrial fibrillation and essential hypertension.
Methods: We performed a study in 54 chronic nonvalvular atrial fibrillation (NVAF) patients (AF group, 28 men and 26 women, aged 58.4Ϯ12.3 years), 40 sinus rhythm patients with the same cardiovascular history as NVAF patients (SR group, 20 men and 20 women, aged 57.6Ϯ11.7 years), and 35 matched healthy control subjects in sinus rhythm (C group, 17 men and 18 women, aged 52.4Ϯ18.5 years). Plasma levels of fibrinogen (FIB), fibrin d-dimer (D-D), tissue plasminogen activator (tPA), its inhibitor (PAI), prothrombin time (PT) , thrombin time (TT) and activated part thromboplastin time (APTT) were measured in plasma from each groups above.
Results: Patients with chronic NVAF had higher plasma FIB, D-D and PAI levels as compared with SR group and C group, While tPA was lower in AF group than the others. There was no significant differences in PT, TT and APTT in the three groups.
Conclusion: There is a hypercoagulation and hypofibrinolysis state in chronic nonvalvular atrial fibrillation patients. 
Introduction:
The 24 hours monitoring blood pressure has allowed the discrimination between hypertension and white coat hypertension. Several works have shown haemorheolgic alterations in hipertensive patients that might be related with the increased risk for cardiovascular events. The objective of the present work was to evaluate if any alteration in haemorheologic parameters was present in the WCH.
Material and Methods: A non-smokers population of 151 individuals, otherwise healthy, except for hypertension, was studied, and divided in normotensives (NT), white coat hypertensives (WCH), and sustained hypertension (HT). All hypertensive patients were under medication. Blood pressure was evaluated using one device Space Lab 90027. WCH defined as office arterial systolic pressure Ն 140 mmHg and diastolic pressure Ն 90, and ambulatory daytime pressures Ͻ 130/80 mmHg. It was determined erythrocyte aggregation, fibrinogen, erythrocyte filtration and plasma viscosity.
It was used the ANOVA statistical model, with the Scheffé's multiple comparison test. It was considered statistically significant values of pϽ0,01 (two-tailed).
Results: There is increasing fibrinogen and plasma viscosity between normotensives and white coat hypertensives, and between those and hypertensives.
Conclusions: The increased fibrinogen and plasma viscosity in WCH suggest that this condition might be also looked as a marker for increased cardiovascular risk.
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